Faruqi & Faruqi, LLP is pleased to announce that on March 13, 2017, Lead Plaintiffs, on behalf of themselves and a class of all persons who purchased or otherwise acquired publicly-traded ACADIA common stock and/or call options in the United States or on the NASDAQ Global Select Market during the period between November 10, 2014 and March 11, 2015, both dates inclusive, reached a settlement with ACADIA Pharmaceuticals Inc., Uli Hacksell, Stephen R. Davis, and Roger G. Mills (“Defendants”), whereby Defendants will pay $2,925,000 in cash to Class Members in exchange for a release of the claims against them. Lead Plaintiffs have moved for preliminary approval of the settlement from the Court. If the Court preliminarily approves the settlement, notice will be sent to Class Members to advise them of their rights to participate in, object to, or seek exclusion from the settlement.
Faruqi & Faruqi, LLP Reaches Settlement On Behalf Of Investors In Acadia Pharmaceuticals Inc.
Finding us
Our Offices
Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
New York
685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331
California
1901 Avenue of the Stars Suite 1060
Los Angeles, California 90067
(424) 256-2884
(424) 256-2885
Georgia
3565 Piedmont Road NE Building Four, Suite 380
Atlanta, Georgia 30305
(404) 847-0617
(404) 506-9534
Pennsylvania
1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771
Faruqi & Faruqi office in New York, New York
Faruqi & Faruqi office in Los Angeles, California
Faruqi & Faruqi office in Atlanta, Georgia
Faruqi & Faruqi office in Philadelphia, Pennsylvania
New York New York 10017